share_log

Lyell Immunopharmashares Are Trading Lower After the Company Released Initial Clinical Data From Its Phase 1 Trial of LYL797.

Lyell Immunopharmashares Are Trading Lower After the Company Released Initial Clinical Data From Its Phase 1 Trial of LYL797.

Lyell免疫制药股价下跌,因公司发布LYL797第一期临床数据。
Benzinga ·  06/27 09:25

Lyell Immunopharmashares Are Trading Lower After the Company Released Initial Clinical Data From Its Phase 1 Trial of LYL797.

Lyell免疫制药股价下跌,因公司发布LYL797第一期临床数据。

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发